Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Short-term Investments: 2023-2025

Historic Short-term Investments for GeneDx Holdings (WGS) over the last 3 years, with Sep 2025 value amounting to $59.1 million.

  • GeneDx Holdings' Short-term Investments rose 0.93% to $59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.1 million, marking a year-over-year increase of 0.93%. This contributed to the annual value of $56.0 million for FY2024, which is 83.72% up from last year.
  • As of Q3 2025, GeneDx Holdings' Short-term Investments stood at $59.1 million, which was down 2.20% from $60.4 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Short-term Investments registered a high of $60.4 million during Q2 2025, and its lowest value of $12.1 million during Q1 2023.
  • Over the past 3 years, GeneDx Holdings' median Short-term Investments value was $53.4 million (recorded in 2024), while the average stood at $44.3 million.
  • Data for GeneDx Holdings' Short-term Investments shows a peak YoY soared of 140.77% (in 2024) over the last 5 years.
  • GeneDx Holdings' Short-term Investments (Quarterly) stood at $30.5 million in 2023, then skyrocketed by 83.72% to $56.0 million in 2024, then rose by 0.93% to $59.1 million in 2025.
  • Its last three reported values are $59.1 million in Q3 2025, $60.4 million for Q2 2025, and $59.5 million during Q1 2025.